Pharmaceutical industry demand growing for the PHT patient-driven eData system and BYOD (Bring Your Own Device) options
PHT Corporation Signs 19 New Trials, Brings eClinical Research to Mobile Phones, Launches Community to Boost Investigator Site Compliance, Hires COO in Q2 2013
<0> For PHT CorporationBrenda Nashawaty, 617-688-3253 </0>
signed 19 new trials, 3 new projects, hired a Chief Operating Officer, and launched 2 major eClinical products during the second fiscal quarter of 2013. PHT is the leading provider of innovative technology systems used to collect for clinical research. PHT developed the LogPad App utilizing the proven PHT electronic Clinical Outcome Assessment ( technology used in 600+ clinical trials by leading pharmaceutical companies.
PHT President and CEO Philip Lee said, “PHT’s growth is accelerating as pharmaceutical sponsors increase their reliance on the PHT eCOA System and Consulting Services to leverage patient-centric research models.”
Phil added, “PHT continues to innovate based on proven technology and the in-depth knowledge and experience which comes from implementing eCOA systems in 600+ trials. Customers are excited about the PHT Team and the ability to work with some of the leading scientific and business minds in the pharmaceutical industry.”
Software Industry Executive Steven Rosenberg Named Chief Operating Officer – Steve Rosenberg has a 30-year track record for growing technology companies through operational excellence. .
The new phtcorp.com – promotes eClinical technology innovation. It showcases information and resources to promote the business, science, and regulatory benefits of adopting PRO and eCOA technologies in clinical research programs that collect patient data.
– PHT launched the LogPad App System that collects compliant clinical research patient data using the latest Apple and Android smartphones including patients’ own devices. The LogPad App gives sponsors and CROs the flexibility to deploy Phase II, III, and IV clinical studies along with post market and observational research, to massive patient populations.
– PHT launched MyStudyHome which connects sponsors with sites to share up-to-date training and documentation, calendars, and study specific updates. MyStudyHome gives pharmaceutical sponsors and CROs a competitive edge in retaining high performing clinical trial investigation sites and improving site engagement and compliance.
Ernst & Young New England Region 2013 Entrepreneur of the Year – For the second consecutive year Phil Lee was named a finalist in this program, considered one of the world’s most prestigious business award programs.
Boston Business Journal’s 100 Largest Private Companies – PHT was cited for exemplifying the spirit of entrepreneurial leadership that makes Massachusetts and the New England region global leaders in technology innovation.
2013 MassTLC Awards – PHT is nominated in four categories: PHT Corporation, for driving eClinical research innovation; Phil Lee, for advancing the eCOA industry; the LogPad App System, for collecting clinical research data from any smartphone; and PHT’s on phtcorp.com.
2013 PRO & eCOA Congress Europe – PHT gathered eClinical innovators in science, academia and business at this event focused on eCOA best practices, regulatory topics and case studies on advancing the collection of compliant patient-driven eData.
The PHT Team also conducted webinars and spoke at meetings including the 2013 PRO Consortium Workshop, the eClinical Forum, and the ISPOR 18th Annual International Meeting. Join PHT at these future industry events:
PHT Corporation helps pharmaceutical companies and CROs conduct clinical trial programs with greater confidence, ease and accuracy. Proven PHT electronic Clinical Outcome Assessment (eCOA) Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via online reporting portal, provides sponsors and clinicians with a real time window into how patients feel and function. PHT has helped trial sponsors collect patient-driven eData in 600+ global trials resulting in 16+ regulatory approvals. PHT offers the regulatory, technological, and scientific expertise today’s market demands and patients deserve. Visit for more information on PHT. Follow PHT on , and .